European Archives - Page 880 of 1422 - European Medical Journal

Dynamic AFP-R and Patient Outcomes After Liver Transplant for Hepatocellular Carcinoma

Karim Halazun, Associate Professor of Surgery, Weill Cornell Medicine, New York City, New York, USA, and colleagues explored whether the dynamic α-fetoprotein response (AFP-R) could improve pre-operative prediction of patient outcomes.

A Novel Immunotherapeutic Approach to Combat Hepatitis B

Globally, chronic hepatitis B virus (HBV) infection is associated with substantial liver-related morbidity and mortality, causing an estimated 800,000 deaths from complications such as cirrhosis and hepatocellular carcinoma. Now, a new immunotherapy strategy identified by researchers at University College London (UCL), UK, could transform the treatment landscape of HBV.

Talking to Ana Rita Ferreira

Ana Rita Ferreira, Region Europe Medical Director, Novartis, discusses cancer care, women in STEM and misinformation.

Promising Results from New Therapy Following Prostatectomy

Promising Results from New Therapy Following Prostatectomy

PENILE form and function can deteriorate over time and is more prominent in males who have undergone a prostatectomy following prostate…

Could This New Discovery Increase the Life Span of Patients Diagnosed with Prostate Cancer?

Could This New Discovery Increase the Life Span of Patients Diagnosed with Prostate Cancer?

Researchers have identified a protein believed to cause prostate cancer to become resistant to treatment by reducing dependency on hormones.

EMJ Podcast: Research and Rock 'n' Roll

In this podcast, we discuss what makes a good physician, explore his research around the mitochondria, and delve into his career as a guitarist in the New York-based band, The Druids of Stonehenge.

EMJ 6.2 Feature Image

Pioneering Best Practices in Atopic Dermatitis: Results from the Quality of Care Initiative

Pioneering global best practices in atopic dermatitis (AD) and implementing them in the clinic are important steps towards optimising patient care…

EMJ 6.2 Feature Image

EMJ 6.2 2021

The second flagship journal of 2021 comprises a selection of articles highlighting key advances across a range of therapeutic disciplines including haematology, rheumatology, respiratory medicine, and more. Themes covered in this issue appeal to a broad range of healthcare professionals and include COVID-19, acute myeloid leukaemia, and Ehlers-Danlos Syndrome, among others.

Late-Breaking Abstracts: Health Status Benefits of Mavacamten in Obstructive Hypertrophic Cardiomyopathy and the Modifying Effect of Ejection Fraction on the Therapeutic Benefit of Omecamtiv Mecarbil in Heart Failure

Two late-breaking abstracts at the American College of Cardiology’s virtual meeting ACC.21 delved further into the data of two pivotal trials

EMJ 6.2 Feature Image

Understanding the Impact of Non-Dystrophic Myotonia on Patients and Caregivers: Results from a Burden of Disease Healthcare Survey

Non-dystrophic myotonias (NDM) manifest as delayed muscle relaxation (myotonia) leading to muscle stiffness that may diminish or worsen…